From August 4, 2022 to September 30, 2022, the company has repurchased 810,839 shares, representing 0.15% for CNY 44.02 million. With this, the company has completed the repurchase of 810,839 shares, representing 0.15% for CNY 44.02 million under the buyback announced on August 4, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.41 CNY | -3.12% | +3.57% | -30.78% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.78% | 1.32B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.